Article ID Journal Published Year Pages File Type
10298689 European Neuropsychopharmacology 2014 12 Pages PDF
Abstract
Taken together, one-year treatment with stimulants or atomoxetine was associated with a clinically significant reduction in ADHD symptoms and mental distress, and improvement of measured function. No serious adverse events were observed.
Related Topics
Life Sciences Neuroscience Biological Psychiatry
Authors
, , , , , ,